GlaxoSmithKline opts to hold on to HIV business
British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.
May 6, 2015
0
5